Inpharma Weekly

, Volume 1542, Issue 1, pp 4–4 | Cite as

SSRIs, TCAs and lofepramine: no difference in cost effectiveness

Clinical study
  • 3 Downloads

Keywords

Serotonin Cost Effectiveness Reuptake Inhibitor Serotonin Reuptake Incremental Cost 

Copyright information

© Adis International Ltd 2006

Personalised recommendations